Merck accused of downplaying early evidence of drug’s brain impact

Norge Nyheter Nyheter

Merck accused of downplaying early evidence of drug’s brain impact
Norge Siste Nytt,Norge Overskrifter
  • 📰 Reuters
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 97%

An early magazine advertisement for Merck’s breakthrough asthma and allergy medicine, Singulair, featured a happy child, hanging upside-down from a tree. Asthmatic kids could now breathe easier, the text assured, and side effects were “usually mild” and “similar to a sugar pill.”

When the drug launched in 1998, its label said the drug’s distribution in the brain was “minimal,” with no mention of psychiatric side effects.

The lawsuits cite the research of Julia Marschallinger, a cell biologist who has studied the drug along with colleagues at the Institute of Molecular Regenerative Medicine in Austria. That team found in 2015 that the drug’s distribution into the brain was more significant than its label described. The FDA cited Marschallinger’s work when it ordered Singlair’s black-box warning label.

Marschallinger and her colleagues in Austria came away with a different finding when they reviewed Merck’s original research and did some of their own. They started looking at Singulair as a potential dementia treatment in 2011. They became interested in that prospect in part because of the reports of psychiatric side effects, such as depression, agitation or hallucinations, from patients and medical providers. While troubling, the side effects showed the drug might affect the brain.

The FDA said Merck’s original animal studies were “quite limited and cannot provide any definitive information about the montelukast levels and activity in the brain.” The agency acknowledged that its reviewer’s description that drug levels declined over time in all tissues “did not fully reflect the data.”

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Reuters /  🏆 2. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Bam Margera leaves detox center early to go to Las Vegas: reportBam Margera leaves detox center early to go to Las Vegas: reportThe “Jackass” alum had been getting help at a facility where Lamar Odom previously sought treatment, but he “didn’t want to complete the program.”
Les mer »

Classic Early Hit Comics Covers by the Legendary Lou Fine, at AuctionClassic Early Hit Comics Covers by the Legendary Lou Fine, at AuctionLou Fine's classic early covers for Quality Comics' Hit Comics make the early issues of the series highly sought after by collectors. LouFine sponsored
Les mer »

Early Amazon Prime Day Deals You Can Get Right NowEarly Amazon Prime Day Deals You Can Get Right NowNo need to wait for July 11-12, some Prime Day bargains are already available.
Les mer »

Risk Of Early Miscarriage Is Higher In Summer — And Experts Say This Is Likely WhyRisk Of Early Miscarriage Is Higher In Summer — And Experts Say This Is Likely WhyA study found a 44 percent higher risk of an early miscarriage in the summer months than in February.
Les mer »

Heisman Trophy future odds: Caleb Williams early favorite to win award againHeisman Trophy future odds: Caleb Williams early favorite to win award againThe Heisman Trophy is not an equal opportunity award. Since 2000, 19 of the 23 winners have played quarterback.
Les mer »



Render Time: 2025-03-04 07:37:02